News
2d
MedPage Today on MSNFDA Advisors Give PTSD Drug Combination a Thumbs Down
"I may have been swayed if this represented a major advance in the field," said panelist Walter Dunn, MD, PhD, of the ...
The prospect of Lundbeck and Otsuka’s Rexulti becoming part of a new treatment for post-traumatic stress disorder (PTSD) ...
PTSD. Learn how trauma fuels chronic shame—and how to change the narrative. Reclaim your voice with compassion and ...
The U.S. Food and Drug Administration's panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma's ...
An FDA advisory panel will meet July 18 to consider a supplemental new drug application for the antipsychotic brexpiprazole, ...
Post Traumatic Stress Disorder, commonly referred to as PTSD is often associated with military veterans but is a human ...
The U.S. Food and Drug Administration's reviewers on Wednesday raised efficacy concerns over the use of Otsuka Pharma's drug ...
The workshop's classes included sessions on post-traumatic stress disorder (PTSD), addictions, depression and many other issues that affect veterans and their families.
The U.S. Food and Drug Administration's reviewers have raised efficacy concerns over Otsuka Pharma's combination drug for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results